UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Nramp2/DMT1 iron transporter is induced in the duodenum of microcytic anemia mk mice but is not properly targeted to the intestinal brush border

Blood, 2000-12, Vol.96 (12), p.3964-3970

2000

Volltextzugriff (PDF)

Expression of the DMT1 (NRAMP2/DCT1) iron transporter in mice with genetic iron overload disorders

Blood, 2001-02, Vol.97 (4), p.1138-1140

2001

Volltextzugriff (PDF)

Nuclear factor-κB activation by the photochemotherapeutic agent verteporfin

Blood, 2000, Vol.95 (1), p.256-262

2000

Volltextzugriff (PDF)

Regulation of iron absorption in Hfe mutant mice

Blood, 2002-08, Vol.100 (4), p.1465-1469

2002

Volltextzugriff (PDF)

Development of Impaired Cytochrome C Oxidase Activity In Apheresis Platelets During Storage

Blood, 2010-11, Vol.116 (21), p.3347-3347

2010

Volltextzugriff (PDF)

Iron Is Hot: An Update on the Pathophysiology of Hemochromatosis

Blood, 1998-09, Vol.92 (6), p.1845-1851

1998

Volltextzugriff (PDF)

Passive Hyperimmune Plasma Therapy in the Treatment of Acquired Immunodeficiency Syndrome: Results of a 12-Month Multicenter Double-Blind Controlled Trial

Blood, 1994-10, Vol.84 (7), p.2130-2135

1994

Volltextzugriff (PDF)

Virological and Immunological Features of Long-Term Human Immunodeficiency Virus–Infected Individuals Who Have Remained Asymptomatic Compared With Those Who Have Progressed to Acquired Immunodeficiency Syndrome

Blood, 1998-11, Vol.92 (9), p.3105-3114

1998

Volltextzugriff (PDF)

Nuclear factor-κB activation by the photochemotherapeutic agent verteporfin

Blood, 2000-01, Vol.95 (1), p.256-262

2000

Volltextzugriff (PDF)

Passive hyperimmune plasma therapy in the treatment of acquired immunodeficiency syndrome: results of a 12-month multicenter double- blind controlled trial. The Passive Hyperimmune Therapy Study Group [see comments]

Blood, 1994-10, Vol.84 (7), p.2130-2135

1994

Volltextzugriff (PDF)

Analysis of human myelogenous leukemia cells in the fluorescence- activated cell sorter using a tumor-specific antiserum

Blood, 1983-05, Vol.61 (5), p.858-866

1983

Volltextzugriff (PDF)

A hitherto undescribed plasma factor acting at the contact phase of blood coagulation (Flaujeac factor): case report and coagulation studies

Blood, 1975-11, Vol.46 (5), p.761-768

1975

Volltextzugriff (PDF)

Dye-mediated photolysis is capable of eliminating drug-resistant (MDR+) tumor cells

Blood, 1993-02, Vol.81 (3), p.793-800

1993

Volltextzugriff (PDF)

Risk of AIDS for recipients of blood components from donors who subsequently developed AIDS

Blood, 1987, Vol.70 (5), p.1608-1610

1987

Volltextzugriff (PDF)

Risk of AIDS for recipients of blood components from donors who subsequently developed AIDS

Blood, 1987-11, Vol.70 (5), p.1604-1610

1987

Volltextzugriff (PDF)

AIDS retrovirus antibodies in hemophiliacs treated with factor VIII or factor IX concentrates, cryoprecipitate, or fresh frozen plasma: prevalence, seroconversion rate, and clinical correlations

Blood, 1986-03, Vol.67 (3), p.592-595

1986

Volltextzugriff (PDF)

The molecular basis of IL-21–mediated proliferation

Blood, 2007-05, Vol.109 (10), p.4135-4142

2007

Volltextzugriff (PDF)

TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection

Blood, 2008-10, Vol.112 (8), p.3508-3516

2008

Volltextzugriff (PDF)

Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists

Blood, 2008-09, Vol.112 (5), p.1750-1758

2008

Volltextzugriff (PDF)

rAAV8-PC Gene Therapy for Severe Protein C Deficiency Using a Novel Murine Model

Blood, 2023-11, Vol.142 (Supplement 1), p.7119-7119

2023

Volltextzugriff (PDF)

Omidubicel-Onlv for Allogeneic Transplantation (allo-HCT) in Patients with Hematologic Malignancies: Results of a Multicenter Open Label Expanded Access Program

Blood, 2023-11, Vol.142 (Supplement 1), p.6894-6894

2023

Volltextzugriff (PDF)

A First-in-Human Phase 1 Study of Abbv-319, an Antibody-Drug Conjugate Composed of a CD19 Antibody Linked to a Potent Proprietary Glucocorticoid Receptor Modulator, in Patients with Relapsed or Refractory B-Cell Malignancies

Blood, 2022-11, Vol.140 (Supplement 1), p.3746-3747

2022

Volltextzugriff (PDF)

Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment

Blood, 2003-01, Vol.101 (2), p.466-468

2003

Volltextzugriff (PDF)

Zanubrutinib in Acalabrutinib-Intolerant Patients (Pts) with B-Cell Malignancies

Blood, 2023-11, Vol.142 (Supplement 1), p.3279-3279

2023

Volltextzugriff (PDF)

Intratumoral CpG, Local Radiation, and Oral Ibrutinib Combine to Produce Effective in Situ Vaccination in Patients with Low-Grade B-Cell Lymphoma

Blood, 2020-11, Vol.136 (Supplement 1), p.48-48

2020

Volltextzugriff (PDF)

1 – 25 von 202

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Zeitschrift / SerieBlood

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(202)
Mit Volltextzugriff
(198)

Publikationsform

Artikel
(202)

Sprache

Englisch
(202)

Erscheinungsjahr

n.n

Kollektion

Menü

Weitere Dienste

Einstellungen

The Nramp2/DMT1 iron transporter is induced in the duodenum of microcytic anemia mk mice but is not properly targeted to the intestinal brush border

Expression of the DMT1 (NRAMP2/DCT1) iron transporter in mice with genetic iron overload disorders

Nuclear factor-κB activation by the photochemotherapeutic agent verteporfin

Regulation of iron absorption in Hfe mutant mice

Development of Impaired Cytochrome C Oxidase Activity In Apheresis Platelets During Storage

Iron Is Hot: An Update on the Pathophysiology of Hemochromatosis

Passive Hyperimmune Plasma Therapy in the Treatment of Acquired Immunodeficiency Syndrome: Results of a 12-Month Multicenter Double-Blind Controlled Trial

Virological and Immunological Features of Long-Term Human Immunodeficiency Virus–Infected Individuals Who Have Remained Asymptomatic Compared With Those Who Have Progressed to Acquired Immunodeficiency Syndrome

Nuclear factor-κB activation by the photochemotherapeutic agent verteporfin

Passive hyperimmune plasma therapy in the treatment of acquired immunodeficiency syndrome: results of a 12-month multicenter double- blind controlled trial. The Passive Hyperimmune Therapy Study Group [see comments]

Analysis of human myelogenous leukemia cells in the fluorescence- activated cell sorter using a tumor-specific antiserum

A hitherto undescribed plasma factor acting at the contact phase of blood coagulation (Flaujeac factor): case report and coagulation studies

Dye-mediated photolysis is capable of eliminating drug-resistant (MDR+) tumor cells

Risk of AIDS for recipients of blood components from donors who subsequently developed AIDS

Risk of AIDS for recipients of blood components from donors who subsequently developed AIDS

AIDS retrovirus antibodies in hemophiliacs treated with factor VIII or factor IX concentrates, cryoprecipitate, or fresh frozen plasma: prevalence, seroconversion rate, and clinical correlations

The molecular basis of IL-21–mediated proliferation

TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection

Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists

rAAV8-PC Gene Therapy for Severe Protein C Deficiency Using a Novel Murine Model

Omidubicel-Onlv for Allogeneic Transplantation (allo-HCT) in Patients with Hematologic Malignancies: Results of a Multicenter Open Label Expanded Access Program

A First-in-Human Phase 1 Study of Abbv-319, an Antibody-Drug Conjugate Composed of a CD19 Antibody Linked to a Potent Proprietary Glucocorticoid Receptor Modulator, in Patients with Relapsed or Refractory B-Cell Malignancies

Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment

Zanubrutinib in Acalabrutinib-Intolerant Patients (Pts) with B-Cell Malignancies

Intratumoral CpG, Local Radiation, and Oral Ibrutinib Combine to Produce Effective in Situ Vaccination in Patients with Low-Grade B-Cell Lymphoma

Aktive Filter

Suchergebnisse filtern